Left atrial appendage obliteration: Mechanisms of healing and intracardiac integration

JACC: Cardiovascular Interventions

Volumn 3, Issue 8, 2010, Pages 870-877

  Schwartz, Robert S ^a   Holmes, David R ^b   Van Tassel, Robert A ^a   Hauser, Robert ^a   Henry, Timothy D ^a   Mooney, Michael ^a   Matthews, Ray ^c   Doshi, Shephal ^d   Jones, Russell M ^e   Virmani, Renu ^e  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b MAYO CLINIC   (United States)

^c GOOD SAMARITAN HOSPITAL   (United States)

^d Pacific Heart Institute   (United States)

^e CVPATH INSTITUTE   (United States)

Author keywords

atrial fibrillation; embolic stroke; left atrial appendage

Indexed keywords

FIBRIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONNECTIVE TISSUE; CONTROLLED STUDY; DEVICE THERAPY; DOG; ENDOCARDIUM; ENDOTHELIUM CELL; GRANULATION TISSUE; HEALING; HEART ATRIUM APPENDAGE; HEART ATRIUM THROMBOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 78651263827     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.04.017     Document Type: Article

References (26)

1. Brais M, Braunwald NS. Acceleration of tissue ingrowth on materials implanted in the heart. Ann Thorac Surg 1976;21:221-9.
2. Little K. Mechanisms of incorporation of homografts and heterografts. Proc R Soc Med 1970;63:999-1002.
3. Kim WG, Sung K, Seo JW. Time-related histopathologic analyses of immunologically untreated porcine valved conduits implanted in a porcine-to-goat model. Artif Organs 2007;31:105-13.
4. Tamura K, Jones M, Yamada I, Ferrans VJ. Wound healing in the mitral valve. J Heart Valve Dis 2000;9:53-63.
5. Lester WM, Gotlieb AI. In vitro repair of the wounded porcine mitral valve. Circ Res 1988;62:833-45.
6. Lyons WS, Kirklin JW. Surgical healing of the atrioventricular leaflets: an experimental study. Surg Forum 1957;8:387-9.
7. Kreutzer J, Ryan CA, Gauvreau K, Van Praagh R, Anderson JM, Jenkins KJ. Healing response to the Clamshell device for closure of intracardiac defects in humans. Catheter Cardiovasc Interv 2001;54: 101-11.
8. Lee TT, De la Torre R, Carrozza JP Jr. Suture-mediated closure of a patent foramen ovale during surgery without cardiopulmonary bypass. Catheter Cardiovasc Interv 2006;68:747-8.
9. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006;48:161-9.
10. Nakazawa G, Finn AV, Virmani R. Vascular pathology of drug-eluting stents. Herz 2007;32:274-80.
11. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
12. Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004;15:313-8.
13. Schwartz RS, Henry TD. Pathophysiology of coronary artery resteno-sis. Rev Cardiovasc Med 2002;3 Suppl 5:S4-9.
14. Lerakis S, Synetos A. Left atrial appendage exclusion system for stroke prevention in atrial fibrillation: a percutaneous device delivery approach. Minerva Cardioangiol 2008;56:667-70.
15. Chiam PT, Ruiz CE. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. J Invasive Cardiol 2008;20:E109-13.
16. Cruz-Gonzalez I, Cubeddu RJ, Sanchez-Ledesma M, et al. Left atrial appendage exclusion using an Amplatzer device. Int J Cardiol 2009; 134:e1-3.
17. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5.
18. Bayard YL, Ostermayer SH, Sievert H. Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev Cardiovasc Ther 2005;3:1003-8.
19. Nakai T, Lesh MD, Gerstenfeld EP, Virmani R, Jones R, Lee RJ. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 2002;105:2217-22.
20. Park JW, Gerk U, Franke RP, Jung F. Post-mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. Cardiology 2009;112:205-8.
21. van den Brand M, Essed CE, Di Mario C, et al. Histological changes in the aortic valve after balloon dilatation: evidence for a delayed healing process. Br Heart J 1992;67:445-9.
22. Nakazawa G, Ladich E, Finn AV, Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury. EuroIntervention 2008;4 Suppl C:C7-10.
23. Nakazawa G, Finn AV, Kolodgie FD, Virmani R. A review of current devices and a look at new technology: drug-eluting stents. Expert Rev Med Devices 2009;6:33-42.
24. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.
25. Hara H, Jones TK, Ladich ER, et al. Patent foramen ovale closure by radiofrequency thermal coaptation: first experience in the porcine model and healing mechanisms over time. Circulation 2007;116: 648-53.
26. Foth R, Quentin T, Michel-Behnke I, et al. Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices. Circ Cardiovasc Interv 2009;2:90-6.